Cannabis modulates six major brain neurotransmitter systems, with profound implications for mental health
A review of preclinical and clinical evidence found cannabinoid receptors modulate dopamine, serotonin, noradrenaline, GABA, glutamate, and opioid systems, explaining the broad range of cannabis effects from pain relief to psychosis risk.
Quick Facts
What This Study Found
CB1 and CB2 receptors interact with six major neurotransmitter systems: dopamine, serotonin, noradrenaline, GABA, glutamate, and opioids. Acute and chronic cannabis exposure produces distinct pharmacological alterations across these systems. The neuromodulatory role of the endocannabinoid system explains why cannabis affects such a wide range of mental health domains.
Key Numbers
6 major neurotransmitter systems modulated: dopamine, serotonin, noradrenaline, GABA, glutamate, opioids. Both CB1 and CB2 receptors involved. Acute and chronic effects differ.
How They Did This
Review summarizing preclinical and clinical data on cannabinoid receptor interactions with major central neurotransmitter systems, covering both acute and chronic exposure effects.
Why This Research Matters
Understanding how cannabinoids interact with established neurotransmitter systems is essential for predicting both therapeutic effects and risks. The breadth of these interactions explains why cannabis has such diverse and sometimes contradictory effects.
The Bigger Picture
Cannabis is not a single-target drug. Its modulatory effects on virtually every major neurotransmitter system explain both its therapeutic versatility and its potential for harm. This complexity demands nuanced approaches to both research and clinical use.
What This Study Doesn't Tell Us
Much of the evidence is preclinical. Translating neurotransmitter-level findings to clinical outcomes is complex. The review covers breadth at the expense of depth for individual neurotransmitter interactions.
Questions This Raises
- ?Can specific neurotransmitter interactions be targeted to maximize therapeutic effects?
- ?Does the serotonin interaction explain CBD anxiolytic effects?
- ?How do different cannabinoid ratios preferentially affect different systems?
Trust & Context
- Key Stat:
- 6 neurotransmitter systems affected
- Evidence Grade:
- Rated moderate because the review synthesizes substantial preclinical and clinical evidence, though individual interactions are at different evidence levels.
- Study Age:
- Published in 2019.
- Original Title:
- Modulatory effects of cannabinoids on brain neurotransmission.
- Published In:
- The European journal of neuroscience, 50(3), 2322-2345 (2019)
- Authors:
- Cohen, Koby(4), Weizman, Abraham(7), Weinstein, Aviv(5)
- Database ID:
- RTHC-01989
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why does cannabis affect so many things?
Cannabinoid receptors modulate six major neurotransmitter systems in the brain: dopamine, serotonin, noradrenaline, GABA, glutamate, and opioids. This explains effects ranging from pain relief to mood changes to psychosis risk.
Are acute and chronic effects different?
Yes. Acute and chronic cannabis exposure produce distinct changes in these neurotransmitter systems, which is why short-term effects often differ from long-term consequences.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- cannabis-effects-and-experience-science
- why-more-creative-when-high-thc-divergent
- thc-and-discipline-daily-use-willpower
- thc-creative-work-artists-musicians-writers
Cite This Study
https://rethinkthc.com/research/RTHC-01989APA
Cohen, Koby; Weizman, Abraham; Weinstein, Aviv. (2019). Modulatory effects of cannabinoids on brain neurotransmission.. The European journal of neuroscience, 50(3), 2322-2345. https://doi.org/10.1111/ejn.14407
MLA
Cohen, Koby, et al. "Modulatory effects of cannabinoids on brain neurotransmission.." The European journal of neuroscience, 2019. https://doi.org/10.1111/ejn.14407
RethinkTHC
RethinkTHC Research Database. "Modulatory effects of cannabinoids on brain neurotransmissio..." RTHC-01989. Retrieved from https://rethinkthc.com/research/cohen-2019-modulatory-effects-of-cannabinoids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.